Advertisement

Neuroscience and Behavioral Physiology

, Volume 39, Issue 4, pp 323–328 | Cite as

Sequelae of Closed Craniocerebral Trauma and the Efficacy of Piracetam in Its Treatment in Adolescents

  • N. N. Zavadenko
  • L. S. Guzilova
Article

The efficacy of piracetam in treating the sequelae of moderate and severe closed craniocerebral trauma (CCT) in adolescents was evaluated in studies of 42 patients aged 12–18 years who had suffered CCT 1.5–5 years prior to the study. Adolescents of the experimental group (20 individuals) received piracetam (Nootropil) at doses of 40–50 mg/kg (daily daily 1600–2400 mg) for one month; patients of group 2 (22 individuals) served as controls. Piracetam was found to have positive therapeutic effects on impairments to higher mental (memory, attention, executive) and motor (coordination) functions and on measures of the speeds of cognitive and motor operations.

Key Words

closed craniocerebral trauma adolescents sequelae long-term period treatment piracetam (Nootropil) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. N. Zavadenko, A. S. Petrukhin, and T. V. Sokolova, “Characteristics of the long-term course of mild craniocerebral trauma in children. Questions of Diagnosis and treatment,” Vestn. Prakt. Nevrol., 3, 80–85 (1997).Google Scholar
  2. 2.
    N. N. Zavadenko, Hyperactivity and Attention Disorder in Childhood [in Russian], Moscow (2005).Google Scholar
  3. 3.
    G. V. Kovalev, Nootropic Substances [in Russian], Volgograd (1990).Google Scholar
  4. 4.
    A. N. Konovalov, L. B. Likhterman, and A. A. Potapova, Craniocerebral Trauma. A Clinical Handbook [in Russian], Moscow 2001, p. 2.Google Scholar
  5. 5.
    G. Craig, The Psychology of Development [Russian translation], St. Petersburg (2002), 7th Edition.Google Scholar
  6. 6.
    Yu. V. Mikadze and N. K. Korsakova, Neuropsychological Diagnosis and Correction in Young Schoolchildren [in Russian], Moscow (2001).Google Scholar
  7. 7.
    T. M. Achenbach, Manual for the Child Behavior Checklist, Burlington (1991).Google Scholar
  8. 8.
    M. B. Denckla, “Revised neurological examination for subtle signs,” Psychopharm. Bull., 21, 773–789 (1985).Google Scholar
  9. 9.
    R. K. Heaton, G. J. Chelune, L. J. Talley, et al., Wisconsin Card Sorting Test Manual (Revised and Expanded, Psychol. Ass. Resources Inc. (1999).Google Scholar
  10. 10.
    J. A. Langlois, W. Rutland-Brown, and K. E. Thomas, Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths, Atlanta, GA (2006), p. 55.Google Scholar
  11. 11.
    K. Leuner, “Pharmacological activities of piracetam and their extrapolated clinical potential,” in: Potential Treatments of the Many Facets of Cognitive Disorders, Athens (2007), pp. 32–35.Google Scholar
  12. 12.
    H. S. Levin, L. Ewing-Cobbs, and H. M. Eisenberg, “Neurobehavioral outcome in pediatric closed head injury,” in: Traumatic Brain Injury in Children, S. H. Broman and M. E. Michel (eds.), Oxford Press (1995), pp. 70–94.Google Scholar
  13. 13.
    H. Levin and S. Chapman, “Contribution of frontal lobe lesions to cognitive deficit after closed head injury in children,” in: Localisation of Brain Lesions and Developmental Functions, D. Riva and A. Benton (eds.), Pediat. Neurol. Ser. (Milan), 9, 97–108 (2000).Google Scholar
  14. 14.
    D. Mendelsohn, H. S. Levin, D. Bruce, et al., “Late MRI after head injury in children: relationship to clinical features and outcome,” Child’s Nervous System, 8, 445–452 (1992).PubMedCrossRefGoogle Scholar
  15. 15.
    J. A. Middleton, “Practitioner review: Psychological sequelae of head injury in children and adolescents,” J. Child. Psychol. Psychiat., 42, 165–180 (2001).PubMedCrossRefGoogle Scholar
  16. 16.
    T. W. Teasdale and A. W. Endberg, “Cognitive dysfunction in young men following head injury in childhood and adolescence: a population study,” J. Neurol. Neurosurg. Psychiat., 74, 933–936 (2003).PubMedCrossRefGoogle Scholar
  17. 17.
    E. Walker, “Risk factors and the neurodevelopmental course of schizophrenia,” Eur. Psychiat., 7, Suppl. 4, 363–369 (2002).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2009

Authors and Affiliations

  • N. N. Zavadenko
    • 1
  • L. S. Guzilova
    • 1
  1. 1.Department of Neurology and Neurosurgery, Faculty of PediatricsRussian State Medical UniversityMoscowRussia

Personalised recommendations